[Report of 276 Pages] The market for renal function tests was valued at US$ 779.1 Mn in 2021, and from 2022 to 2032, it is anticipated to grow at a CAGR of 5.6%. By the end of 2032, the market is anticipated to have a US$ 1,414.5 Mn estimated valuation. With a market share of about 62.4% …
Category Archives: Healthcare Trends
Cranial Stabilisation Devices Market is set to reach a valuation of US$ 988.4 Million by 2032
[Report of 198 Pages] By the end of 2022, the market for cranial stabilisation devices is projected to be worth US$ 615.2 Mn, up from US$ 582.2 Mn in 2021. The overall sales of cranial stabilisation devices are anticipated to increase at a CAGR of 4.9% between 2022 and 2032, reaching a total of approximately US$ 988.4 …
Germany Blood Warmer Devices Market is set to witness a lucrative CAGR of 7.4% from 2022 to 2032
[Report of 276 Pages] The market for blood warmer devices is anticipated to grow at a 7.6% CAGR from 2022 to 2032, reaching a valuation of US$ 451.2 Mn in 2022. By the end of 2032, the market is expected to be worth about US$ 937.5 Mn. In terms of products, intravenous warming systems are the market …
The overall positive air pressure devices market in Europe is expected to expand at 5.8% CAGR from 2022 to 2032
[Report of 215 Pages] The size of the global market for positive air pressure devices was US$ 2.3 billion in 2021, and by the end of 2022, it is anticipated to be worth US$ 2.5 billion. Aside from that, the overall demand for positive air pressure devices is anticipated to increase at a CAGR of 6.4% between …
Europe breathing circuits market is expected to register a CAGR of 4.2% from 2022 to 2032 | FMI
[Report of 279 Pages] By the end of 2022, the market for breathing circuits is anticipated to be worth US$ 1,163.32 Mn and grow at a CAGR of 4.2% from 2022 to 2032. By the end of 2032, the market is projected to be worth US$ 1,758.18 million. In 2021, open breathing circuits dominated the market with …
Demand for tinea pedis treatment in Europe is expected to register a growth at 5.2% CAGR from 2022 to 2032
[Report of 286 Pages] The market for treating tinea pedis is anticipated to reach US$ 1.35 billion in 2022 and then grow at a CAGR of 5.2% to reach US$ 2.24 billion by the end of 2032. The interdigital tinea pedis treatment market is anticipated to hold the top spot in terms of disease indication in 2022 …
Vascular Closure Devices Market are projected to rise at 5.4% CAGR between 2022 and 2032
[Report of 250 Pages] The size of the global market for vascular closure devices was US$ 1.3 billion in 2021, and by the end of 2022, it is anticipated to be worth US$ 1.4 billion. Additionally, due to the increasing use of vascular closure devices for the immediate sealing of an artery following medical procedures, the market’s …
The Microscope Digital Cameras Market in Japan is set to expand at a prolific CAGR of 10.3% from 2022 to 2032
[Report of 384 Pages] The market for microscope digital cameras was valued at US$ 675.3 million in 2021, and by the end of 2022, it is anticipated to reach US$ 741.5 million. Additionally, due to growing adoption in hospitals, clinics, research labs, and the biotechnology sector, the global sales of microscope digital cameras are anticipated to soar …
Neonatal Phototherapy Devices Market size is estimated to cross US$ 142.13 Million by 2032
Neonatal jaundice is a major concern amongst new-borns and is a common cause of morbidity in the crucial first few months of life. Approx. 80% of preterm new-borns can suffer from neonatal jaundice making its effective treatment a critical health issue. Future Market Insights has conducted an exhaustive study on the neonatal phototherapy devices market in its …
Rare Neurological Disease Treatment Market worldwide are poised to surpass US$ 19.795.14 Million by 2032-end
[170 Pages Report] According to a newly published Future Market Insights report, the global rare neurological disease treatment market will exhibit a splendid expansion throughout the forecast period (2017-2026). Revenues from the market are envisaged to exceed US$ 12,000 Mn by 2026-end. New Drug Formulations and Initiatives toward Improving Treatment & Care of Patients to Influence Market …